Blocking the CTLA-4 and PD-1 pathways during pulmonary paracoccidioidomycosis improves immunity, reduces disease severity, and increases the survival of infected mice.

Saved in:
Bibliographic Details
Title: Blocking the CTLA-4 and PD-1 pathways during pulmonary paracoccidioidomycosis improves immunity, reduces disease severity, and increases the survival of infected mice.
Authors: Preite NW; Institute of Science and Technology, Federal University of São Paulo, São Paulo, Brazil., Borges BM; Institute of Science and Technology, Federal University of São Paulo, São Paulo, Brazil., Kaminski VL; Institute of Science and Technology, Federal University of São Paulo, São Paulo, Brazil., Ayupe MC; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo (USP), São Paulo, Brazil., Gonçalves LM; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo (USP), São Paulo, Brazil., Dos Santos BV; Institute of Science and Technology, Federal University of São Paulo, São Paulo, Brazil., Fonseca DLM; Institute of Mathematics and Statistics (IME), University of Sao Paulo (USP), Sao Paulo, Brazil., Filgueiras IS; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo (USP), São Paulo, Brazil., Salgado CL; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo (USP), São Paulo, Brazil., Muxel SM; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo (USP), São Paulo, Brazil., Cabral-Marques O; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo (USP), São Paulo, Brazil.; Department of Medicine, Division of Molecular Medicine, University of São Paulo School of Medicine (USP), São Paulo, Brazil.; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo (USP), São Paulo, Brazil.; Network of Immunity in Infection, Malignancy, Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), São Paulo, Brazil., da Fonseca DM; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo (USP), São Paulo, Brazil., Loures FV; Institute of Science and Technology, Federal University of São Paulo, São Paulo, Brazil., Calich VLG; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo (USP), São Paulo, Brazil.
Source: Frontiers in immunology [Front Immunol] 2024 Mar 04; Vol. 15, pp. 1347318. Date of Electronic Publication: 2024 Mar 04 (Print Publication: 2024).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38500881
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Blocking the CTLA-4 and PD-1 pathways during pulmonary paracoccidioidomycosis improves immunity, reduces disease severity, and increases the survival of infected mice.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Preite+NW%22">Preite NW</searchLink>; Institute of Science and Technology, Federal University of São Paulo, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Borges+BM%22">Borges BM</searchLink>; Institute of Science and Technology, Federal University of São Paulo, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Kaminski+VL%22">Kaminski VL</searchLink>; Institute of Science and Technology, Federal University of São Paulo, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Ayupe+MC%22">Ayupe MC</searchLink>; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo (USP), São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Gonçalves+LM%22">Gonçalves LM</searchLink>; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo (USP), São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Dos+Santos+BV%22">Dos Santos BV</searchLink>; Institute of Science and Technology, Federal University of São Paulo, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Fonseca+DLM%22">Fonseca DLM</searchLink>; Institute of Mathematics and Statistics (IME), University of Sao Paulo (USP), Sao Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Filgueiras+IS%22">Filgueiras IS</searchLink>; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo (USP), São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Salgado+CL%22">Salgado CL</searchLink>; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo (USP), São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Muxel+SM%22">Muxel SM</searchLink>; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo (USP), São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Cabral-Marques+O%22">Cabral-Marques O</searchLink>; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo (USP), São Paulo, Brazil.; Department of Medicine, Division of Molecular Medicine, University of São Paulo School of Medicine (USP), São Paulo, Brazil.; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo (USP), São Paulo, Brazil.; Network of Immunity in Infection, Malignancy, Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22da+Fonseca+DM%22">da Fonseca DM</searchLink>; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo (USP), São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Loures+FV%22">Loures FV</searchLink>; Institute of Science and Technology, Federal University of São Paulo, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Calich+VLG%22">Calich VLG</searchLink>; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo (USP), São Paulo, Brazil.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2024 Mar 04; Vol. 15, pp. 1347318. <i>Date of Electronic Publication: </i>2024 Mar 04 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38500881
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2024.1347318
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1347318
    Titles:
      – TitleFull: Blocking the CTLA-4 and PD-1 pathways during pulmonary paracoccidioidomycosis improves immunity, reduces disease severity, and increases the survival of infected mice.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Preite NW
      – PersonEntity:
          Name:
            NameFull: Borges BM
      – PersonEntity:
          Name:
            NameFull: Kaminski VL
      – PersonEntity:
          Name:
            NameFull: Ayupe MC
      – PersonEntity:
          Name:
            NameFull: Gonçalves LM
      – PersonEntity:
          Name:
            NameFull: Dos Santos BV
      – PersonEntity:
          Name:
            NameFull: Fonseca DLM
      – PersonEntity:
          Name:
            NameFull: Filgueiras IS
      – PersonEntity:
          Name:
            NameFull: Salgado CL
      – PersonEntity:
          Name:
            NameFull: Muxel SM
      – PersonEntity:
          Name:
            NameFull: Cabral-Marques O
      – PersonEntity:
          Name:
            NameFull: da Fonseca DM
      – PersonEntity:
          Name:
            NameFull: Loures FV
      – PersonEntity:
          Name:
            NameFull: Calich VLG
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 03
              Text: 2024 Mar 04
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1